Another opportunity to connect in Boston


ProQinase will attend the Tumor Models Boston Summit from 16-18 July 2018.
A special focus will be put on mouse-derived isografts, a novel set of syngeneic mouse models that allows to investigate the dynamics of different immune cell populations.
Dr. Bettina Stahnke will be on-site to answer your questions.